Shui, Yifang
26  Ergebnisse:
Personensuche X
?
3

PD-L1 antibody enhanced β-glucan antitumor effects via bloc..:

Hu, Xin ; Shui, Yifang ; Hirano, Hiroshi...
Cancer Immunology, Immunotherapy.  72 (2022)  3 - p. 719-731 , 2022
 
?
4

Retracted: MicroRNA‐4429 restrains colorectal cancer cell i..:

Li, Hongwen ; Liang, Weijie ; Zhang, Hongyu..
Journal of Cellular Physiology.  236 (2021)  8 - p. 5875-5884 , 2021
 
?
5

β-glucan from Aureobasidium pullulans augments the anti-tum..:

Shui, Yifang ; Hu, Xin ; Hirano, Hiroshi...
International Immunopharmacology.  101 (2021)  - p. 108265 , 2021
 
?
10

Osterix Decreases the Chemosensitivity of Breast Cancer Cel..:

Wu, Jiahui ; Chen, Xiang ; Bao, Qianyi...
Cellular Physiology and Biochemistry.  44 (2017)  3 - p. 998-1010 , 2017
 
?
13

Combined phospholipids adjuvant augments anti-tumor immune ..:

Shui, Yifang ; Hu, Xin ; Hirano, Hiroshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018555/.  , 2023
 
?
14

Down-regulation of RBP4 indicates a poor prognosis and corr..:

Li, Mingxing ; Wang, Zhihui ; Zhu, Lixu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055798/.  , 2021
 
?
15

A pooled analysis of the prognostic value of PD-L1 in melan..:

Yang, Jing ; Dong, Meilian ; Shui, Yifang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106672/.  , 2020
 
1-15